UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors

ESMO open, 2019, Vol.4 (4), p.e000531, Article e000531

2019

Volltextzugriff (PDF)

Real-World Evidence Study of Patients with KRAS -Mutated NSCLC in Finland

Current oncology (Toronto), 2024-05, Vol.31 (5), p.2700-2712

2024

Volltextzugriff (PDF)

Comparison of Targeted Next-Generation Sequencing (NGS) and Real-Time PCR in the Detection of EGFR, KRAS, and BRAF Mutations on Formalin-Fixed, Paraffin-Embedded Tumor Material of Non-Small Cell Lung Carcinoma-Superiority of NGS

Genes chromosomes & cancer, 2013-05, Vol.52 (5), p.503-511

2013

Volltextzugriff (PDF)

PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK‐rearranged lung cancer

Molecular oncology, 2023-05, Vol.17 (5), p.747-764

2023

Volltextzugriff (PDF)

Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research

Virchows Archiv : an international journal of pathology, 2020-02, Vol.476 (2), p.273-283

2020

Volltextzugriff (PDF)

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer

Cancer medicine (Malden, MA), 2023-08, Vol.12 (15), p.16087-16097

2023

Volltextzugriff (PDF)

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread

Endocrine Connections, 2019-08, Vol.8 (8), p.1168-1175

2019

Volltextzugriff (PDF)

Protocol to utilize fresh uncultured human lung tumor cells for personalized functional diagnostics

STAR protocols, 2022-12, Vol.3 (4), p.101720-101720, Article 101720

2022

Volltextzugriff (PDF)

Modification of Clearview Tuberculosis (TB) Enzyme-Linked Immunosorbent Assay for TB Patients Not Infected with HIV

Clinical and Vaccine Immunology, 2013-09, Vol.20 (9), p.1479-1482

2013

Volltextzugriff (PDF)

A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer

Lung cancer (Amsterdam, Netherlands), 2012-10, Vol.78 (1), p.63-69

2012

Volltextzugriff (PDF)

Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study

Lung cancer (Amsterdam, Netherlands), 2010-12, Vol.70 (3), p.347-351

2010

Volltextzugriff (PDF)

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

The Lancet (British edition), 2014-05, Vol.383 (9928), p.1561-1571

BURDETT, Sarah

2014

Volltextzugriff (PDF)

Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors

The journal of clinical endocrinology and metabolism, 2019-06, Vol.104 (6), p.2083-2093

2019

Volltextzugriff (PDF)

Real-World Evidence Study of Patients with IKRAS/I-Mutated NSCLC in Finland

Current oncology (Toronto), 2024-05, Vol.31 (5)

2024

Volltextzugriff (PDF)

Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer

Anticancer research, 2018-10, Vol.38 (10), p.5627-5634

2018

Volltextzugriff (PDF)

Oxidative stress in non-small cell lung cancer: Role of nicotinamide adenine dinucleotide phosphate oxidase and glutathione

Acta oncologica, 2009, Vol.48 (7), p.1054-1061

2009

Volltextzugriff (PDF)

The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data

Chest, 2019-03, Vol.155 (3), p.502-509

2019

Volltextzugriff (PDF)

Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor

Acta oncologica, 2018-08, Vol.57 (8), p.1109-1116

2018

Volltextzugriff (PDF)

Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing

Oncotarget, 2017-03, Vol.8 (11), p.18166-18176

2017

Volltextzugriff (PDF)

Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review

Genes chromosomes & cancer, 2016-12, Vol.55 (12), p.905-914

2016

Volltextzugriff (PDF)

Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors

Journal of molecular medicine (Berlin, Germany), 2005-12, Vol.83 (12), p.976-983

2005

Volltextzugriff (PDF)

PI3Kβ inhibition enhances ALK#8208;inhibitor sensitivity in ALK#8208;rearranged lung cancer

Molecular oncology, 2023-05, Vol.17 (5), p.747

2023

Volltextzugriff (PDF)

Hot spot mutations in Finnish non-small cell lung cancers

Lung cancer (Amsterdam, Netherlands), 2016-09, Vol.99, p.102-110

2016

Volltextzugriff (PDF)

Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study

Acta oncologica, 2023-06, Vol.62 (6), p.587-593

2023

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)
magazinearticle
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(39)
Female
(27)
Male
(27)
Middle Aged
(23)
Oncology
(23)
Aged
(22)
Adult
(20)
Lung Cancer
(14)
Lung Neoplasms - Genetics
(13)
Lung Neoplasms - Pathology
(13)
Aged, 80 And Over
(12)
Tumors
(12)
Carcinoma, Non-Small-Cell Lung - Genetics
(11)
Carcinoma, Non-Small-Cell Lung - Pathology
(10)
Mutation
(10)
Respiratory System
(9)
Biological And Medical Sciences
(8)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors

Real-World Evidence Study of Patients with KRAS -Mutated NSCLC in Finland

Comparison of Targeted Next-Generation Sequencing (NGS) and Real-Time PCR in the Detection of EGFR, KRAS, and BRAF Mutations on Formalin-Fixed, Paraffin-Embedded Tumor Material of Non-Small Cell Lung Carcinoma-Superiority of NGS

PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK‐rearranged lung cancer

Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread

Protocol to utilize fresh uncultured human lung tumor cells for personalized functional diagnostics

Modification of Clearview Tuberculosis (TB) Enzyme-Linked Immunosorbent Assay for TB Patients Not Infected with HIV

A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer

Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

Real-World Evidence Study of Patients with IKRAS/I-Mutated NSCLC in Finland

Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer

Oxidative stress in non-small cell lung cancer: Role of nicotinamide adenine dinucleotide phosphate oxidase and glutathione

The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data

Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor

Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing

Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review

Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors

PI3Kβ inhibition enhances ALK#8208;inhibitor sensitivity in ALK#8208;rearranged lung cancer

Hot spot mutations in Finnish non-small cell lung cancers

Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study

Suchergebnisse filtern